Valuation Albert David Limited NSE India S.E.

Stocks

Market Closed - NSE India S.E. 07:05:07 2026-08-21 EDT			5-day change	1st Jan Change
864.15 ^INR	+0.12%		+6.36%	+17.32%

08-06	Albert David Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
08-06	Albert David Limited Approves Appointment of Mr. Amit Mahla as Whole-Time Director, effective 19 June, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026
Market Cap ¹	2,150	3,034	2,921	6,139	4,630	3,350
Change	-	41.11%	-3.71%	110.15%	-24.58%	-27.65%
Enterprise Value (EV) ¹	677.4	1,343	942.3	3,320	2,317	1,070
Change	-	98.22%	-29.82%	252.36%	-30.23%	-53.81%
P/E	9.71x	8.61x	8.08x	8.14x	26.9x	-224x
PBR	0.88x	1.09x	0.94x	1.6x	1.18x	0.86x
PEG	-	0.1x	3.11x	0x	-0.3x	2x
Capitalization / Revenue	0.87x	0.97x	0.86x	1.69x	1.34x	1x
EV / Revenue	0.27x	0.43x	0.28x	0.92x	0.67x	0.32x
EV / EBITDA	3.82x	3.43x	2.18x	7.21x	102x	22.4x
EV / EBIT	6.21x	4.2x	2.6x	8.29x	-60.5x	-26.6x
EV / FCF	1.98x	3.58x	-21.4x	8.85x	-6.17x	-2.9x
FCF Yield	50.4%	28%	-4.68%	11.3%	-16.2%	-34.5%
Dividend per Share ²	6	9	9	11.5	5	5
Rate of return	1.59%	1.69%	1.76%	1.07%	0.62%	0.85%
EPS ²	38.8	61.78	63.39	132.1	30.14	-2.619
Distribution rate	15.5%	14.6%	14.2%	8.7%	16.6%	-191%
Net sales ¹	2,474	3,135	3,416	3,625	3,458	3,336
EBITDA ¹	177.4	391.5	431.6	460.7	22.66	47.87
EBIT ¹	109.2	319.9	362.4	400.6	-38.27	-40.25
Net income ¹	221.4	352.6	361.7	754.2	172	-14.95
Net Debt ¹	-1,473	-1,691	-1,979	-2,819	-2,313	-2,280
Reference price ²	376.75	531.65	511.90	1,075.75	811.30	587.00
Nbr of stocks (in thousands)	5,707	5,707	5,707	5,707	5,707	5,707
Announcement Date	8/20/21	7/14/22	5/19/23	7/12/24	7/5/25	7/13/26

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
SUN PHARMACEUTICAL INDUSTRIES LTD.	35.13x	6.59x	22.83x	0.9%	47.74B
OTSUKA HOLDINGS CO., LTD.	19.22x	2.3x	10.4x	1.35%	41.7B
CIPLA LIMITED	27.99x	3.41x	17.65x	0.9%	12.14B
ZYDUS LIFESCIENCES LIMITED	26.56x	3.8x	15.76x	0.61%	11.55B
KRKA, D. D.	18.7x	3.32x	11.56x	3.86%	9.18B
GEDEON RICHTER	9.03x	2.08x	5.42x	4.46%	7.54B
ONO PHARMACEUTICAL CO., LTD.	16.16x	2.11x	6.87x	3.16%	7.35B
GLENMARK PHARMACEUTICALS LIMITED	28.37x	3.7x	17.22x	0.16%	6.88B
Average	22.65x	3.41x	13.46x	1.92%	18.01B
Weighted average by Cap.	25.54x	4.05x	15.52x	1.46%